Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edmund J Lewis

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 3, 2003
Ancient clinical trialsEdmund J Lewis
BMJ (Clinical Research Ed.)|May 28, 2005
Angiotensin receptor blockers and myocardial infarction: results reflect different cardiovascular states in patients with types 1 and 2 diabetesEdmund J Lewis,
Seminars in Nephrology|April 10, 2007
Treating hypertension in the patient with overt diabetic nephropathyEdmund J Lewis
Nephron. Physiology|May 20, 2009
The enigma of cellular immunity in glomerulonephritis: lupus nephritis is not necessarily a prototype of immune complex-mediated glomerulonephritisEdmund J Lewis
American Journal of Hypertension|October 18, 2002
The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetesEdmund J Lewis
American Journal of Hypertension|January 9, 2003
Angiotensin II receptor blockade in diabetic nephropathyEdmund J Lewis
Diabetes Care|February 15, 2008
Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparinEdmund J Lewis, Xiulong Xu
Journal of Nephrology|January 8, 2003
Rewriting the histological classification of lupus nephritisMelvin M Schwartz, Edmund J Lewis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 27, 2011
Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuriaStephen M Korbet, Edmund J Lewis,
Clinical and Experimental Nephrology|October 31, 2003
Treatment of diabetic nephropathy with angiotensin II receptor antagonistEdmund J Lewis, Julia B Lewis
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 3, 2003
Ancient clinical trialsEdmund J Lewis
BMJ (Clinical Research Ed.)|May 28, 2005
Angiotensin receptor blockers and myocardial infarction: results reflect different cardiovascular states in patients with types 1 and 2 diabetesEdmund J Lewis,
Seminars in Nephrology|April 10, 2007
Treating hypertension in the patient with overt diabetic nephropathyEdmund J Lewis
Nephron. Physiology|May 20, 2009
The enigma of cellular immunity in glomerulonephritis: lupus nephritis is not necessarily a prototype of immune complex-mediated glomerulonephritisEdmund J Lewis
American Journal of Hypertension|October 18, 2002
The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetesEdmund J Lewis
American Journal of Hypertension|January 9, 2003
Angiotensin II receptor blockade in diabetic nephropathyEdmund J Lewis
Diabetes Care|February 15, 2008
Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparinEdmund J Lewis, Xiulong Xu
Journal of Nephrology|January 8, 2003
Rewriting the histological classification of lupus nephritisMelvin M Schwartz, Edmund J Lewis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 27, 2011
Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuriaStephen M Korbet, Edmund J Lewis,
Clinical and Experimental Nephrology|October 31, 2003
Treatment of diabetic nephropathy with angiotensin II receptor antagonistEdmund J Lewis, Julia B Lewis
Pageof 5